Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines Podcast Por  arte de portada

Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines

Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

In this expert-led video, Stacey Johnson, NP-C, from the Montana Arthritis Center, breaks down the 2024 ACR Guidelines for Lupus Nephritis and highlights key treatment strategies—including hydroxychloroquine dosing, steroid pulse and taper regimens, and the role of triple therapy. Learn how to tailor treatment for Class III, IV, and V Lupus Nephritis using combinations like mycophenolate, belimumab, calcineurin inhibitors, and low-dose cyclophosphamide.

These updated recommendations emphasize precision and safety, focusing on minimizing steroid exposure while maximizing disease control through multi-targeted immune therapy.


For more rheumatology insights and clinical updates, visit the Content Rheum at RhAPP.org or download the RhAPP ACE app.


#LupusNephritis #ACRGuidelines #RheumatologyEducation #SteroidTapering #Belimumab #Hydroxychloroquine #Mycophenolate #TripleTherapy #AutoimmuneDisease #RhAPP #ContentRheum

adbl_web_global_use_to_activate_webcro805_stickypopup
Todavía no hay opiniones